[Recalled] Implantable Cardioverter Defibrillators (ICDs), Visia AF. Labeled as: a. Visia AF VR ICD DF1 (Product No. DVAB1D1); EXPANSION: b. Visia AF" VR ICD DF4 (Product No. DVAB1D4) Implantable devices that automatically de
The product on this page is subject to an official recall. We summarise the regulator's findings and the recommended action.
Recall details
| Product | Implantable Cardioverter Defibrillators (ICDs), Visia AF. Labeled as: a. Visia AF VR ICD DF1 (Product No. DVAB1D1); EXPANSION: b. Visia AF" VR ICD DF4 (Product No. DVAB1D4) Implantable devices that automatically detect and treat episodes of ventricular fibrillation, ventricular tachyc |
|---|---|
| Brand / manufacturer | Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF) |
| Category | device |
| Issuing authority | FDA_DEVICE |
| Reference | Z-0589-2018 |
| Country of notice | United States |
| Risk level | Class I |
| Hazard type | recall |
| Notice date | 19 December 2017 |
| EAN / barcode | 00643169566347 |
Why it was recalled
According to the FDA_DEVICE notice, the identified hazard is: Possible prevention of high and low voltage therapy in Medtronic Implantable Cardioverter Defibrillators (ICDs) and Cardiac Resynchronization Therapy Defibrillator (CRT-D).
This Class I recall concerns device products distributed in United States and was recorded by FDA_DEVICE. Recalls in this category are published so that owners, retailers, and importers can identify affected units and act quickly.
What to do if you own this product
Stop using the product immediately and follow the authority's remedy (return, repair, or disposal).
Read the full official notice →
Related recalls from Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
This page indexes a public government recall notice for reference. We do not sell or verify this product; always confirm the current status on the authority's official site.